IP Verse

Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor - EP2256135

PATENT ANALYSIS

Patent Details

Grant Date
Mar 13, 2019
Company
CSL BEHRING GMBH
Oppositions

BIOVERATIV THERAPEUTICS, INC./SWEDISH ORPHAN BIOVITRUM AB (PUBL)

More patents of Csl Behring Gmbh

EP3564267

EP2256135

Want to monitor this patent?

Feel free to send us a message here and we will get back to you